ALG3 as a PanCancer Oncogene: Bioinformatics Analysis and Identification ofSmall-Molecule Inhibitors
The study first reported potential inhibitors of human ALG3 based on a molecular modelling approach. This opens the way for future experimental investigations of the testing of these lead compounds in ALG3-high cancer models.
Authors
- Sameh S. Elhady (ORCID: https://orcid.org/0000-0003-3799-0581)
- Waleed K. Abdulsahib (ORCID: https://orcid.org/0000-0002-8851-5783)
- Hanadi A. Katouah (ORCID: https://orcid.org/0000-0001-9044-2491)
- Eman Elsayed Fayad (ORCID: https://orcid.org/0000-0003-2916-0254)
- Khaled M. Darwish (ORCID: https://orcid.org/0000-0002-0597-482X)
- Dalal Sulaiman Alshaya (ORCID: https://orcid.org/0000-0002-0682-8189)
- Mohammed Alshehri (ORCID: https://orcid.org/0000-0001-5355-5868)
- Muhammad Alaa Eldeen (ORCID: https://orcid.org/0000-0001-5280-7736)
- Mohamed O. Andarawi
- Hassan M. Otifi (ORCID: https://orcid.org/0000-0002-1735-6041)
- Aiysha Althobaiti
- Hesham M. Hassan (ORCID: https://orcid.org/0000-0002-8029-914X)
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Suez Canal University (EG)
- Taif University (SA)
- King Abdulaziz University (SA)
- Zagazig University (EG)
- Umm al-Qura University (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
- Iraqi University (IQ)
- Andalas University (ID)
- King Khalid University (SA)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-11-03
- DOI
- https://doi.org/10.2174/0118715206395527250902101008
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00